Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate

被引：0
|
作者：
Roy Fleischmann
Boulos Haraoui
Maya H. Buch
David Gold
Gosford Sawyerr
Harry Shi
Annette Diehl
Kristen Lee
机构：
[1] Metroplex Clinical Research Center and University of Texas Southwestern Medical Center,Centre for Musculoskeletal Research
[2] Institut de Rhumatologie de Montréal,undefined
[3] University of Manchester,undefined
[4] and NIHR Manchester Biomedical Research Centre,undefined
[5] Pfizer Canada ULC,undefined
[6] Pfizer Inc,undefined
[7] Pfizer Inc,undefined
来源：
Rheumatology and Therapy | 2023年 / 10卷
关键词：
Rheumatoid arthritis; Inflammation; Methotrexate; Therapeutics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：375 / 386
页数：11
相关论文
共 50 条
  • [21] METHOTREXATE WITHDRAWAL IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO ACHIEVE LOW DISEASE ACTIVITY WITH TOFACITINIB MODIFIED-RELEASE 11 MG ONCE DAILY plus METHOTREXATE: A RANDOMISED NON-INFERIORITY PHASE 3B/4 STUDY
    Cohen, Stanley B.
    Pope, Janet
    Haraoui, Boulos
    Irazoque-Palazuelos, Fedra
    Korkosz, Mariusz
    Diehl, Annette
    Luis Rivas, Jose
    Lukic, Tatjana
    Liu, Shixue
    Stockert, Lori
    Iikuni, Noriko
    Keystone, Edward
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 260 - 261
  • [22] Etanercept or Methotrexate Withdrawal in Rheumatoid Arthritis Patients in Sustained Remission
    Curtis, Jeffrey R.
    Emery, Paul
    Karis, Elaine
    Haraoui, Boulos
    Bykerk, Vivian
    Yen, Priscilla K.
    Kricorian, Greg
    Chung, James B.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 759 - 768
  • [23] ACHIEVEMENT AND MAINTENANCE OF REMISSION/LOW DISEASE ACTIVITY OVER 24 MONTHS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ETANERCEPT OR ETANERCEPT plus METHOTREXATE IN THE CANADIAN METHOTREXATE AND ETANERCEPT OUTCOME (CAMEO) STUDY
    Pope, J. E.
    Haraoui, B.
    Thorne, J. C.
    Phan-Chronis, K.
    Poulin-Costello, M.
    Vieira, A.
    Keystone, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 240 - 240
  • [24] Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Florentinus, Stefan
    Chen, Su
    Suboticki, Jessica L.
    Kavanaugh, Arthur
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (11) : 1566 - 1572
  • [25] Alendronate in rheumatoid arthritis patients treated with methotrexate and glucocorticoids
    Lale Yilmaz
    Kürşat Özoran
    Osman Hakan Gündüz
    Halil Uçan
    Metin Yücel
    Rheumatology International, 2001, 20 : 65 - 69
  • [26] CIRRHOSIS IN RHEUMATOID-ARTHRITIS PATIENTS TREATED WITH METHOTREXATE
    APONTE, J
    PETRELLI, M
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S340 - S340
  • [27] Malignancy in patients with rheumatoid arthritis treated with methotrexate - Reply
    Usman, AR
    Yunus, MB
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (04) : 806 - 807
  • [28] GYNECOMASTIA IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED WITH METHOTREXATE
    THOMAS, E
    LEROUX, JL
    BLOTMAN, F
    JOURNAL OF RHEUMATOLOGY, 1994, 21 (09) : 1777 - 1778
  • [29] Homocysteine level in patients with rheumatoid arthritis treated with methotrexate
    Stanislavchuk, Mykola A.
    Galyutina, Olena Y.
    RHEUMATOLOGY, 2008, 47 : II102 - II102
  • [30] Liver Fibrosis in Rheumatoid Arthritis Patients Treated with Methotrexate
    Hilal, Ghizlane
    Akasbi, Nessrine
    Boudouaya, Hanae
    Salma, Ksir
    Harzy, Taoufik
    CURRENT RHEUMATOLOGY REVIEWS, 2020, 16 (04) : 293 - 297
12345